Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McInnes

Showing results (271-280 of 537) with videos related to

Pageof 54
Sort By:
Clinical and Experimental Immunology|December 17, 2008
An investigation of the impact of the location and timing of antigen-specific T cell division on airways inflammationS Hutchison, B S W Choo-Kang, V B Gibson, et al.
Brain, Behavior, and Immunity|August 11, 2015
Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humansRajeev Krishnadas, Alice Nicol, Jen Sassarini, et al.
Annals of the Rheumatic Diseases|June 10, 2019
Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept studySophie Glatt, Peter C Taylor, Iain B McInnes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2012
Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β productionMoritz Haneklaus, Motti Gerlic, Mariola Kurowska-Stolarska, et al.
Metabolites|June 14, 2020
Changes in Plasma Itaconate Elevation in Early Rheumatoid Arthritis Patients Elucidates Disease Activity Associated Macrophage ActivationRónán Daly, Gavin Blackburn, Cameron Best, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 26, 2016
Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic ArthritisDésirée van der Heijde, Robert B Landewé, Philip J Mease, et al.
Nature Medicine|February 1, 1996
The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritisI B McInnes, J al-Mughales, M Field, et al.
European Journal of Immunology|November 6, 2007
IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 productionWaldiceu A Verri, Thiago M Cunha, Sérgio H Ferreira, et al.
Rheumatology (Oxford, England)|February 11, 2024
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritisDennis McGonagle, Arthur Kavanaugh, Iain B McInnes, et al.
The British Journal of Dermatology|April 29, 2021
Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy studyA B Gottlieb, J F Merola, K Reich, et al.
Pageof 54

Showing results (271-280 of 537) with videos related to

Sort By:
Pageof 54
Clinical and Experimental Immunology|December 17, 2008
An investigation of the impact of the location and timing of antigen-specific T cell division on airways inflammationS Hutchison, B S W Choo-Kang, V B Gibson, et al.
Brain, Behavior, and Immunity|August 11, 2015
Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humansRajeev Krishnadas, Alice Nicol, Jen Sassarini, et al.
Annals of the Rheumatic Diseases|June 10, 2019
Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept studySophie Glatt, Peter C Taylor, Iain B McInnes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2012
Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β productionMoritz Haneklaus, Motti Gerlic, Mariola Kurowska-Stolarska, et al.
Metabolites|June 14, 2020
Changes in Plasma Itaconate Elevation in Early Rheumatoid Arthritis Patients Elucidates Disease Activity Associated Macrophage ActivationRónán Daly, Gavin Blackburn, Cameron Best, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 26, 2016
Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic ArthritisDésirée van der Heijde, Robert B Landewé, Philip J Mease, et al.
Nature Medicine|February 1, 1996
The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritisI B McInnes, J al-Mughales, M Field, et al.
European Journal of Immunology|November 6, 2007
IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 productionWaldiceu A Verri, Thiago M Cunha, Sérgio H Ferreira, et al.
Rheumatology (Oxford, England)|February 11, 2024
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritisDennis McGonagle, Arthur Kavanaugh, Iain B McInnes, et al.
The British Journal of Dermatology|April 29, 2021
Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy studyA B Gottlieb, J F Merola, K Reich, et al.
Pageof 54